Core Laboratories Inc. /DE/ CLB
NYSE · stock · Oil & Gas Field Services, NEC · website · IPO 2018-10-22
Core Laboratories Inc. /DE/ financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M | $489.7M | $470.3M |
| Operating income | $56.5M | $58.6M | $54.6M | $41.5M | $45.3M |
| Interest expense | $10.6M | $12.4M | $13.4M | $11.6M | $9.2M |
| Income tax | $15.5M | $14.0M | $4.2M | $10.3M | $15.9M |
| Net income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M |
| EPS (diluted) | $0.63 | $0.66 | $0.77 | $0.42 | $0.42 |
| Operating cash flow | $37.0M | $56.4M | $24.8M | $25.0M | $36.6M |
| Free cash flow | $25.8M | $44.5M | $14.2M | $14.7M | $23.0M |
| Cash & equivalents | $22.7M | $19.2M | $15.1M | $15.4M | — |
| Inventory | $54.5M | $59.4M | $71.7M | $60.4M | — |
| Total assets | $584.0M | $585.1M | $586.4M | $578.4M | $580.9M |
| Shareholders' equity | $272.2M | $252.3M | $224.8M | $184.3M | $161.0M |
Growth · year-over-year · Revenue CAGR 2.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | +0.5% | +2.8% | +4.1% | +4.1% | — |
| Net income growth | -5.5% | -14.4% | +88.5% | -1.4% | — |
| EPS growth | -4.5% | -14.3% | +83.3% | +0.0% | — |
| Free cash flow growth | -42.0% | +213.2% | -3.6% | -36.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.